Johnson & Johnson (JNJ)Rep. Scott Scott Franklin (FL18) disclosed a sale $15K–$50K
Rep. Scott Scott Franklin (FL18) disclosed a sale of Johnson & Johnson in the $15K–$50K range.
- $15,001–$50,000
- Reported range · official band, not an exact amount
- 28 days
- Disclosure lag
- Traded
- Jun 16, 2025
- Disclosed
- Jul 14, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Mar 15, 2023CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Aug 7, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Sep 26, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Oct 29, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Mar 19, 2025CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
- Mar 24, 2025CongressDisclosed sale of JNJ — reported range $100,001 - $250,000
- Apr 1, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
- Apr 8, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
- Apr 9, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
- Apr 21, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
- Apr 29, 2025Congress · 1 personMembers of Congress: 2 sales
- May 5, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- May 12, 2025CongressDisclosed sale of JNJ — reported range $50,001 - $100,000
- May 30, 2025CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
- Jun 10, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Jun 12, 2025CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
- Jun 16, 2025 · this disclosureCongressDisclosed sale of JNJ — reported range $15,001 - $50,000
What came next
- Jun 17, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Jun 24, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
- Jul 17, 2025InsiderOfficer sold ~$3.13M of JNJ shares in the open market
- Jul 31, 2025CongressDisclosed partial sale of JNJ — reported range $15,001 - $50,000
- Aug 4, 2025Congress · 1 personMembers of Congress: 2 purchases
- Aug 14, 2025FDAFDA drug approval: Rybrevant
- Aug 14, 2025FDAFDA drug approval: Lazcluze
- Aug 14, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
- Aug 15, 2025FDARecall: STRATAFIX Spiral PDS Plus Bidirectional Knotless Tissue Control Device, SFX SPI PDS+ BI VIO 14X14IN(36X36CM) USP1(M4) D/A MO-4. Product Code: SXPP2B400-11.
- Aug 15, 2025InsiderCFO sold ~$2.98M of JNJ shares in the open market
- Aug 19, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
- Aug 20, 2025FDARecall: Automated Impella Controller (AIC) with the below brands and product codes. Used with heart assist pump. 1. Impella Controller, Packaged, US; Product Code: 004…
- Aug 22, 2025FDAFDA device clearance: CARTO 3 EP Navigation System V8.1
- Aug 22, 2025InsiderCEO sold ~$22.5M of JNJ shares in the open market
- Sep 4, 2025Insider · 4 days before an 8-KOfficer sold ~$10M of JNJ shares in the open market
- Sep 8, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 8, 2025, Johnson & Johnson (the Company) announced that John Morikis was elected to the Board of Directors. The Board has determined that Mr. Morikis satisfies the applicable independence requirements of the NYSE Listed Company Manual.”
- Sep 9, 2025FDAFDA drug approval: Inlexzo
- Sep 11, 2025FDARecall: ECHELON LINEAR Cutters Reload 80 mm Blue, intended for transection, resection, and/or creation of anastomoses, Product Number GLC80
- Sep 16, 2025FDARecall: Automated Impella Controller (AIC) labeled as the following with corresponding Product Codes: 1. AIC w/Impella Connect for ECP, Product Code: 1000432. 2. Dbl o…
- Sep 19, 2025FDAFDA drug approval: Tremfya
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Johnson & Johnson
For Johnson & Johnson, OQRO holds 15 insider filings (SEC Form 4 or Form 144), 8 Congress trade reports, 167 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.
Other recent filings by Rep. Scott Scott Franklin (FL18)
- House Clerk periodic transaction report at Accenture (ACN)Sep 17, 2026
- House Clerk periodic transaction report at Accenture (ACN)Sep 17, 2026
- House Clerk periodic transaction report at Apple (AAPL)Sep 17, 2026
- House Clerk periodic transaction report at JPMorgan Chase (JPM)Sep 17, 2026
- House Clerk periodic transaction report at JPMorgan Chase (JPM)Sep 17, 2026
The full history of Rep. Scott Scott Franklin (FL18) is on the profile page.
How this filing works
Other disclosures at Johnson & Johnson
- House Clerk periodic transaction reportOct 5, 2026
- USAspending.gov award recordOct 5, 2026
- USAspending.gov award recordSep 22, 2026
- USAspending.gov award recordSep 21, 2026
- House Clerk periodic transaction reportSep 12, 2026
- Senate eFD periodic transaction reportSep 11, 2026
Everything OQRO holds on this company is on its JNJ page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
